Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions

British Journal of Cancer

Volumn 76, Issue 10, 1997, Pages 1353-1360

  Bontkes, H J ^a   De Gruijl, T D ^a   Walboomers, J M M ^a   Van Den Muysenberg, A J C ^a   Gunther, A W ^a   Scheper, R J ^a   Meijer, C J L M ^a   Kummer, J A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical carcinoma; Cervical dysplasia; Cytotoxic T lymphocyte; Granzyme B; Major histocompatibility complex

Indexed keywords

CD8 ANTIGEN; GRANZYME B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE ANTIGEN; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN TISSUE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0030724380     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.560     Document Type: Article

References (38)

1. Anderson P (1996) TIA-1: Structural and functional studies on a new class of cytotoxic effector molecule.Curr Topics Microbiol Immunol 198: 131-143
2. Coleman N, Birley HDL, Renton AM, Hanna NF, Ryait BK, Byrne M, Taylorrobinson D and Stanley MA (1994) Immunological events in regressing genital warts. Am J Clin Pathol 102: 768-774
3. Connor ME and Stern PL (1990) Loss of MHC class-I expression in cervical carcinoma. Int J Cancer 46: 1029-1034
4. Cromme FV, Meijer CJLM, Snijders PJF, Uyterlinde A, Kenemans P, Helmerhorst T, Stern PL, Van den Brule AJC and Walboomers JMM (1993) Analysis of MHC class-I and class-II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. Br J Cancer 67: 1372-1380
5. Cromme FV, Walboomers JMM, Stukart MJ, de Gruijl TD, Kummer JA, Leonhart AM, Helmerhorst TJM and Meijer CJLM (1995) Lack of granzyme expression in T lymphocytes indicates poor cytotoxic T lymphocyte activation in human papillomavirus-associated cervical carcinomas. Int J Cancer 5: 366-373
6. Frisan T, Sjoberg J, Dolcetti R, Boiocchi M, De Re V, Carhone A, Brauthar C, Battat C, Biberfeld P, Eckman M, Ost A, Christensson B, Sundstrom C, Bjorkholm M, Pisa P and Masucci MG (1995) Local suppression of Epstein Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86: 1493-1501
7. Giacomini P, Aguzzi A, Pestka S, Fisher PB and Ferrone S (1984) Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells. J Immunol 133: 1649-1655
8. Griffihs GM and Müller C (1991) Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells, Immunol Today 12: 415-119
9. Hulpert R, Fruchter RG, Sedlis A. Butt K, Boyce JG and Sillman FH (1986) Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 68: 251-258
10. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH and Ley TL (1994) Cytotoxic lymphocytes require granzymes B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987
11. Ho GYF, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R and Romney S (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365-1371
12. Honma S, Tsukada S, Honda S, Nakamura M, Takakuwa K, Maruhashi T, Kodama S, Kanazawa K, Takahashi T and Tanaka K (1994) Biological-clinical significance of selective loss of HLA-class-I allelic product expression in squamous-cell carcinoma of the uterine cervix. Int J Cancer 57: 650-655
13. IARC (1995) The Human Papillomavirus, Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol. 64, International Agency for Research on Cancer: Lyon
14. Isaaz S, Baetz K, Olsen K, Podack E and Griffiths GM (1995) Serial killing by cytotoxic T lymphocyes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur J Immunol 25: 1071-1079
15. Jenne DH and Tschopp J (1988) Granzymes, a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation. Immunol Rev 103: 53-71
16. Kägi D, Seiler P, Pavlovic J, Lederman B, Zinkernagel RM and Hengartner H (1995) The roles of perforin- and Fas-dependent cytotoxicily in protection against cytopathic and noncytopathic viruses. Eur J Immunol 25: 3256-3262
17. Kealing PJ, Cromme FV, Duggan-Keen M, Snijders PJF, Walboomers JMM, Hunter RD, Dyer PA and Stern PL (1995) Frequency of down regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br J Cancer 72: 405-411
18. Kummer JA, Kamp AM, van Katwijk M, Brakenhoff JPJ, Radosevic K, van Leeuwen AM, Borst J, Verweij CL and Hack CE (1993) Production and characterization of monoclonal and polyclonal antibodies raised against recombinant human granzymes A and B and cross reacting with the natural proteins. J Immunol Methods 163: 77-83
19. Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJLM and Hack CF (1995) Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol 100: 164-172
20. Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Rynder RW, Vermund SH, Heyward WL, Nelson A and Reeve WC (1992) Genital papillomavirus infection and cervical dysplasia - opportunistic complications of HIV infection. Int J Cancer 48: 682-688
21. Lanier LL and Phillips JH (1966) Inhibitory MHC class I receptors on NK cells and T-cells. Immunol Today 17: 86-100
22. Lichtenheld MG, Olsen KL, Lu P, Lowrey DM, Hameed A, Hengartner H and Podack ER (1988) Structure and function of human perforin. Nature 448-451
23. Liu CC, Rafii S, Granelli-Piperno A, Trapani JA and Young J-E (1989) Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med 170: 2105-2118
24. Merchentaler I, Stankovies I and Gallyas F (1989) A highly sensitive one-step method for silver intensification of the nickle-diaminobenzidine end product of peroxidase reaction. J Histochem Cytochem 37: 1563-1565
25. Muller C and Tschopp J (1994) Resistance of CTL to perforin-mediated lysis Evidence for a lymphocyte membrane protein interacting with perforin J Immunol 153: 2470-2478
26. Nishioka WK and Welsh RM (1994) Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target. J Exp Med 179: 769-774
27. Oudejans JJ, Jiwa NM, Kummer JA, Horstman A, Vos W, Baak JPA, Kluin PM, van der Valk P, Walboomers JMM and Meijer CJLM (1996) Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotocix T-cell response in Epstein-Barr virus positive and negative Hodgkin's disease. Blood 87: 3844-3851
28. Poppema S and Visser L (1994) Absence of HLA class I expression by Reed-Sternberg cells Am J Pathol 145: 37-41
29. Remmink AJ, Walboomers JMM, Helmerhorst TJM, Voorhorst FJ, Rozendaal L, Risse EKJ, Meijer CJLM and Kenemans P (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306-311
30. Rivoltini L, Barracchini KC, Viggiano V, Kawakami Y, Smith A, Mixon A, Restifo NP, Topalian SL, Simonis TB, Rosenberg SA and Marincola FM (1995) Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res 55: 3149-3157
31. Sale GE, Beauchamp L and Myerson D (1994) Immunohistologic staining of cytotoxic T and NK cells in formalin-fixed paraffin embedded tissue using microwave TIA-1 antigen retrieval. Transplantation 57: 287-289
32. Stam NJ, Uroom TM, Peters PJ, Pastoors EB and Ploegh HL (1990) HLA-A and HLA-B specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin fixed paraffin-embedded tissue sections and cryoimmumo-electron microscopy, Int Immunol 3: 113-125
33. ter Harmsel B, Smedts F, Kuijpers J, Jeunink M, Trimbos B and Ramaekers F (1996) Bcl-2 immunoreactivity increases with severity of CIN: A study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 179: 26-30
34. Tian Q, Streuli M, Saito H, Schlossman SF and Anderson P (1991) A polyadenylate binding proteins localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67: 629-639
35. Ucker DS, Wilson JD and Hebshi LD (1995) Target cell death triggered by cytotoxic lymphocytes: a larget cell mutant distinguishes passive pore formation and active cell suicide mechanism. Eur J Immunol 25: 1163-1167
36. Van den Brule AJC, Meijer CJLM, Bakels V, Kenemans P and Walboomers JMM (1990) Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 28: 2739-2743
37. Xie JW and Gallagher G (1994) The ability of transforming growth factor-beta I to preferentially inhibit the induction of cytotoxicity in human T cells is determined by the nature of the activating signals. Anticancer Res 14: 1595-1598
38. Zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human pupillomavirus types. In Human Pathogenic Papillomaviruses, pp. 131-156. Springer: Berlin